穴位埋线结合中胚层疗法治疗单纯性肥胖

目的探讨穴位埋线结合中胚层疗法治疗单纯性肥胖的方法。方法对78例患者行辨证分型的治疗原则,每种分型治疗两组穴位。将特定埋线针刺入穴位,达到一定深度（即中胚层）,待局部有酸、胀、麻感后,将线埋入体内。两组穴位交替进行,15d一次,3次为一个疗程。结果78例患者经过一个疗程的治疗,体重下降至标准体重的16例,显效42例,有效14例,无效6例。总有效率为92%。78例患者治疗前平均体重82.24kg,治疗后平均体重76.18kg,平均减少6.06kg。结论穴位埋线与中胚层疗法治疗单纯性肥胖疗效明显,治疗次数少,省时、经济、疗效好,作用持久,患者痛苦小,依从性好,值得进一步研究。     

穴位埋线法治疗单纯性肥胖症

目的:探讨穴位埋线治疗单纯性肥胖症的-临床疗效.方法:将126例单纯性肥胖症患者随机分为治疗组(埋线法)56例和对照组(口服西药西布曲明)70例,对治疗前后体重、腰围、臀围、F%、BMI指数比较.结果:两组治疗前后五项指数比较,P＜0.05疗效;两组疗效比较,P＞0.05,说明两组疗效无明显差异.对于腰围、臀围指标的改善治疗组优于对照组.结论:穴位埋线法治疗简便易行,疗效显著,其塑形效果好,值得临床推广.     

穴位埋线对单纯性肥胖症瘦素和胰岛素抵抗影响的研究

目的:探讨穴位埋线疗法对单纯性肥胖症瘦素和胰岛素抵抗的作用.方法:采用RT-PCR技术测定瘦素受体(OB-R)基因表达水平,放射免疫分析测定血清和下丘脑瘦素(Leptin)和胰岛素(INS)的含量.观察穴位埋线疗法治疗前后单纯性肥胖患者血清Leptin、INS、脂质水平的变化;还观察穴位埋线疗法治疗前后肥胖大鼠体重、Lee's 指数、体脂、血清和下丘脑瘦素和INS 的含量以及下丘脑OB-R基因表达的变化.结果:单纯性肥胖患者Leptin、INS、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白-胆固醇(LDL-C) 的含量均显著高于正常人水平;而高密度脂蛋白-胆固醇(HDL-C)却显著低于正常人水平,穴位埋线疗法治疗后患者Leptin、INS、TC、TG、LDL-C的含量均明显回降,而HDL-C含量却明显回升,这种变化与减肥疗效有关.肥胖大鼠体重、Lee's 指数、体脂及血清Leptin和INS 水平均显著高于正常大鼠,而下丘脑瘦素和INS水平及OB-R 基因表达水平均明显低于正常大鼠.穴位埋线疗法治疗取得良好减肥疗效的同时,肥胖大鼠血清瘦素和INS 均明显回降,而下丘脑瘦素和INS水平以及OB-R基因表达水平却明显升高.结论:穴位埋线疗法对肥胖机体中枢和外周Leptin和INS水平的良性调整作用以及促进下丘脑OB-R基因表达可能是穴位埋线疗法纠正瘦素和胰岛素抵抗以及异常的内分泌代谢的重要机制.     

穴位埋线治疗单纯性肥胖症疗效观察

目的 观察穴位埋入羊肠线治疗单纯性肥胖症的效果.方法 将64例单纯性肥胖症患者随机分为对照组和观察组各32例,两组治疗期间不使用减肥药物和其它减肥方法,按要求合理膳食及适当运动,观察组同时采用穴位埋线治疗,对照组采用针刺穴位疗法,观察治疗前后体重和腰围变化,并评价减肥疗效.结果 观察组总有效率为90.63%,对照组总有效率87.5%,两组比较,差异无显著性意义(P＞0.05);两组治疗后腰围和体重较治疗前显著下降(均P＜0.05),且观察组下降水平优于对照组.结论 穴位埋线治疗减肥方便易行、疗效满意,减轻了患者的痛苦,是一种较满意的减肥方法.     

穴位埋线疗法治疗单纯性肥胖症远期疗效观察

目的：观察穴位埋线疗法治疗单纯性肥胖症的远期疗效。方法：以辨证论治选穴,穴位埋线治疗3个疗程,前后自身对照观察,每次选6～10个穴位。结果：96例患者治疗后体重、体围、皮脂厚度、BMI、F%、WHR、瘦素（Leptin）、Ins、TG、TC、FBS等指标都有不同程度的降低,治疗前后比较,经统计学分析,差异均有显著意义（P〈0.05）。结论：该疗法具有疗效高、方便、安全、无痛苦、持续作用长、无副作用等特点,提示穴位埋线疗法治疗单纯性肥胖症具有减重、降脂、重塑体形和良好的远期疗效。     

穴位埋线治疗单纯性肥胖症疗效观察

目的观察穴位埋入羊肠线治疗单纯性肥胖症的效果。方法将64例单纯性肥胖症患者随机分为对照组和观察组各32例，两组治疗期间不使用减肥药物和其它减肥方法，按要求合理膳食及适当运动，观察组同时采用穴位埋线治疗．对照组采用针刺穴位疗法，观察治疗前后体重和腰围变化，并评价减肥疗效。结果观察组总有效率为90．63％，对照蛆总有效率87．5％，两组比较，差异无显著性意义（P〉0．05）；两组治疗后腰围和体重较治疗前显著下降（均P〈0.05），且观察组下降水平优于对照组。结论穴位埋线治疗减肥方便易行、疗效满意，减轻了患者的痛苦，是一种较满意的减肥方法。     

中医辨证配合穴位埋线治疗肥胖症患者的疗效观察

目的:观察中医辨证配合耳针穴位埋线治疗肥胖症患者的疗效。方法:将我院116例肥胖症患者随机分为两组。对照组:患者常规性针灸治疗,治疗组采用中医辨证配合耳针穴位埋线治疗。7天为1个疗程,治疗2个疗程后对比临床效果。结果:治疗组总有效率为93.1%,对照组70.7%,疗效比较有显著性差异(P0.05)。两组患者在治疗过程中均未出现不良反应,患者的体重与体重指数对比存在较大差异性,且差异具有统计学意义(P0.05)。结论:中医辨证配合耳针穴位埋线治疗肥胖症患者疗效高于常规性针灸治疗,且治疗全面、有效,减少了并发症的发生,安全性较高。     

穴位埋线联合药杖华佗夹脊穴治疗单纯性肥胖症疗效观察

目的:优选提高单纯性肥胖症疗效方案。方法:将100例患者随机分为穴位埋线联合药杖华佗夹脊穴组(治疗组)及毫针法单独体针操作组(对照组),每组各50例,并进行临床疗效对比观察。结果:两组分别于45天后比较疗效,治疗组总有效率(96.18%),与对照组(79.86%)相比具有显著性差异(P0.01)。结论:穴位埋线联合药杖华佗夹脊穴治疗单纯性肥胖症总有效率优于单独体针操作,疗效稳定,不易反弹,且较针刺疗法方便,疗效持久。     

饮食指导、运动和耳穴贴压减肥法

目的:观察耳穴贴压联合教育干预等综合措施减肥的效果。方法:对145例单纯性肥胖患者用中药王不留行籽贴压一侧耳廓所选穴位,每周换贴另一侧耳廓并测量体重,12周为一个疗程。在每次换贴时均给予患者心理和行为的教育指导,观察所绘体重曲线图的走向。结果:145例患者中体重减轻>5.0kg共58例(40%),体重减轻1.5～5.0kg共83例(57.2%),体重减轻<1.5kg共4例(2.7%)。结论:耳穴贴压联合教育干预能有效治疗单纯性肥胖症。     

穴位埋线联合强脉冲光治疗炎症性痤疮疗效观察

目的:观察穴位埋线联合强脉冲光治疗炎症性痤疮的临床疗效。方法:选取来自于门诊的痤疮患者180例,随机分为穴位埋线组、强脉冲光组、穴位埋线联合强脉冲光组,每组60例。穴位埋线组:取肺俞、血海及关元,肺俞为主穴位,交替配以关元或血海。将羊肠线埋入对应穴位皮下处,每2周埋线治疗1次;强脉冲光组:选择合适的能量密度9~13J/cm2,脉宽30~50ms,每周治疗1~2次;穴位埋线联合强脉冲光组:患者穴位埋线同时给予强脉冲光照射治疗。均连续观察8周。结果:统计8周末各组疗效,强脉冲光组治愈率和有效率高于穴位埋线组,两组间比较差异无显著性意义(P0.05);穴位埋线联合强脉冲光组分别与强脉冲光组和穴位埋线组的治愈率、总有效率比较,差异有显著性意义(P0.01、0.05);三组有效病例随访半年,穴位埋线组、穴位埋线联合强脉冲激光组的复发率与强脉冲激光组比较,差异有统计学意义(P0.05)。结论:穴位埋线联合强脉冲光治疗炎症性痤疮有显著的协同作用,且疗效稳定,不易复发。     

脐周八穴针罐结合治疗单纯性肥胖症疗效观察

目的：观察脐周八穴针罐结合治疗单纯性肥胖症的临床疗效。方法：将95例单纯性肥胖症患者随机分为治疗组和对照组,治疗组（50例）采用脐周八穴为主穴,分别为滑肉门、天枢、外陵、水分、阴交,采用针灸结合火罐的治疗方法;对照组（45例）采用口服曲美,每天10mg,两组均治疗8周。分别对两组患者治疗前及治疗8周后的体重、体质指数（BMI）、腰臀比（WHR）、体脂百分率（F%）进行测定,观察其减肥的效果。结果：治疗组和对照组总有效率分别为98.00%及97.78%。与对照组比较,治疗组总有效率、体重、体质指数均无显著差异（P〉0.05）,但WHR、F%均低于对照组（P〈0.05）。结论：脐周八穴针罐疗法治疗单纯性肥胖症与口服曲美总有效率相当,而脐周八穴针罐疗法更能显著改善肥胖患者的WHR、F%,且安全、无不良反应。     

Biliopancreatic Diversion for Treatment of Morbid Obesity: Experience in 50 Cases

Background: Biliopancreatic diversion (BPD) by Scopinaro's method is an operation advocated by some surgeons as an effective treatment for morbid obesity. Methods: Between February 1995 and April 1997 we performed BPD by Scopinaro's method on 50 patients with morbid obesity (23 males), average age 41.4 years (range 20-63 years), average body weight 135.08 kg (range 89-256 kg), mean body mass index (BMI) 50.65 kg/m² (range 37.01-81.56 kg/m²). Results: In all cases a gradual decrease in weight was obtained [mean BMI at 1 month: 44.8 kg/m², at 6 months (31 patients): 35.09 kg/m², at 1 year (23 patients): 31.36 kg/m², at 18 months (14 patients): 29.89 kg/m² and at 2 years (5 patients): 29.27 kg/m²]. At the same time a significant improvement in the pathological conditions associated with morbid obesity was observed. The patients were able to suspend oral antihypertensive and antidiabetic therapy as these parameters spontaneously returned to normal values by the sixth postoperative month; all cases showed a marked reduction in hypercholesterolemia and hypertriglyceridemia. Postoperative complications were: one death (2%) on the third day due to heart failure; two late intestinal occlusions (4%); one acute dilatation of the stomach (2%); one peritonitis caused by early dehiscence of the anastomosis (2%); five anastomotic ulcers (10%); two cases of protein malnutrition (4%). Conclusions: BPD by Scopinaro's method is a bariatric procedure which is technically complex. However is it safe and reproducible and it induces a substantial weight loss.     

中药膳食配合运动干预对肥胖性脂肪肝的影响

目的探讨中药膳食配合运动干预对肥胖性脂肪肝的影响.方法将68例脂肪肝患者随机分为对照组和观察组各34例.对照组常规给予低脂饮食和易善复、大黄庶虫丸等降酶保肝治疗;观察组按常规方法治疗外,采用中医辨证施食予以活血化淤、健脾利湿的中药膳食疗法配合运动干预,疗程均为1年.结果治疗后观察组体重、甘油三酯、总胆固醇、谷丙转氨酶等显著低于对照组(均P<0.01).结论中药膳食配合运动干预对肥胖性脂肪肝疗效显著.     

Composition of weight loss in morbidly obese patients after gastric bypass

Optimal treatment of morbid obesity requires reduction of excess body fat while minimizing lean tissue loss. In order to determine if gastric bypass surgery satisfies both these requirements, we have studied changes in body composition and weight loss in adult (mean age = 33 years) morbidly obese patients (14 males, 68 females) after gastric bypass surgery. The preoperative weight of this cohort was 136 ± 27 (SD) kg, which was 228 ± 37% of ideal body weight by actuarial standards. Lean body mass (LBM) was estimated from potassium-40 measurements obtained from a wholebody potassium-40 counter and by urine creatinine excretion on a subgroup of 20 patients. The average weight loss at 3, 6, and 12 months after surgery was 25, 35, and 46 kg, respectively. The weight loss phase lasted approximately 1 year, at which time 34% of the initial weight was lost and the percentage of loss of excess weight above ideal body weight plateaued at 61%. LBM accounted for 32% of the total weight loss at 1 month, 11% at 6 months, and only 3% at the end of 1 year. The percentage of body weight represented by LBM increased from 35% prior to surgery to 51% by 18 months after gastric bypass. Actual LBM content increased steadily after the first month following surgery. Mean total weight loss following three different surgical procedures for gastric bypass did not differ significantly. Gastric bypass surgery appears to satisfy the objectives of reducing excess weight contributed by fat while minimizing lean tissue loss in morbidly obese patients.     

Mesotherapy and Phosphatidylcholine Injections: Historical Clarification and Review

BACKGROUND: Mesotherapy was originally conceived in Europe as a method of utilizing cutaneous injections containing a mixture of compounds for the treatment of local medical and cosmetic conditions. Although mesotherapy was traditionally employed for pain relief, its cosmetic applications, particularly fat and cellulite removal, have recently received attention in the United States. Another treatment for localized fat reduction, which was popularized in Brazil and uses injections of phosphatidylcholine, has been erroneously considered synonymous with mesotherapy. Despite their attraction as purported "fat-dissolving" injections, the safety and efficacy of these novel cosmetic treatments remain ambiguous to most patients and physicians. OBJECTIVE: To distinguish mesotherapy from phosphatidylcholine injections by reviewing their history and the relevant experimental or clinical findings. METHODS: A comprehensive search of Medline indexed literature and conference proceedings. RESULTS: All the published studies evaluating the clinical efficacy of traditional mesotherapy currently originate from Europe. These reports focus primarily on musculoskeletal pain and vascular disease, rather than cosmetic applications. Although experimental data suggest that a number of traditional mesotherapy ingredients may theoretically reduce fat, these effects have not been supported in peer-reviewed studies. An increasing number of reports demonstrate that subcutaneous injections of a formula containing phosphatidylcholine combined with its emulsifier, deoxycholate, are effective in removing small collections of adipose tissue. Cell lysis, resulting from the detergent action of deoxycholate, may account for this clinical effect. CONCLUSIONS: Mesotherapy is distinct from a method of treating adipose tissue with subcutaneous injections of deoxycholate alone or in combination with phosphatidylcholine. Additional clinical and experimental studies are necessary to more definitively establish the safety and efficacy of these treatments.     

Results of surgical formation of small stomach in patients with morbid obesity

The authors conducted a comparative analysis of the results of surgical treatment of patients with alimentary-constitutional adiposity (ACA) of extreme degrees. Operation for the formation of a small stomach (SSF) was carried out in 41 patients. The results in the same patients were analysed in postoperative periods of more than 2 years. The patients were divided into 2 groups. The first group was composed of 22 patients with morbid obesity and an average body weight of 140.2 +/- 4.47 kg (101.4 +/- 3.83% excess weight). The second group was made up of 19 patients with an average body weight of 170.2 +/- 6.5 kg (average excess weight 169.8 +/- 7.03%). The average weight loss in the first group was 41.9 kg (59.9% loss of excessive weight), the average weight loss in patients with hyperadiposis (second group) was 62.9 kg (99.4% loss of excessive weight). The results of operation for SSF for reducing body weight in patients with adiposity are better than those of vertical gastroplasty.     

Risk factors and complications after body‐contouring surgery and the amount of stromal vascular fraction cells found in subcutaneous tissue

Body contouring surgery following massive weight loss is often prone to complications. Subcutaneous adipose tissue is a rich source of stromal vascular fraction (SVF) cells, and moreover it plays an important role in the pathophysiology of obesity, metabolic syndrome, and wound healing. In this retrospective, single‐centred appraisal, complications are examined and correlated with individual SVF numbers in abdominal subcutaneous fat tissue. We analysed whether the weight loss method affected complications. Eighty seven massive weight loss patients undergoing body contouring surgery between 2010 and 2017 were included in the study. In total, 57 cases with at least one complication were recorded (65.5%). Maximum lifetime weight was 109.6 kg (range 48‐184 kg). Half of the complications (50.8%) were minor complications without the need for surgical revision. The mean number of SVF found in the resected tissue was 714 997.63 cells/g fat tissue. We found no statistical difference in complication rates dependent on cell numbers. Smoking (P = .049) and a high BMI at the time point of surgery (P = .031) led to significantly more complications. Also, a high resection weight (P = .057) showed a tendency for impaired wound healing. However, there was no difference in complication rates following body contouring procedures attributable to the method of weight loss in this study.     

Late results of the treatment of patients with the extreme degree of alimentary-constitutional obesity by the method of formation of a small stomach]

The work analyses the results of treatment of 311 patients with extreme degrees of alimentary-constitutional obesity by formation of a small stomach. Fatal outcomes (1.9%) were encountered in the period of operative technique mastering. The late-term results were studied in 167 patients in follow-up periods of up to 3 years. The patients' average body weight was 149.4 kg, average height 166.2 cm, average body weight excess as compared to the ideal weight was 125.6%. Study of the late-term results of the operation showed that the postoperative weight loss depends on the initial weight excess and the diameter of the anastomosis formed between the proximal and distal parts of the stomach. The more the initial excess of weight as compared to the ideal value, the more the loss of body weight is. The diameter of the formed anastomosis should be no larger than 15 mm. Besides loss of weight, the activity of vital organs and systems is normalized after the operation, and arterial hypertension, diabetes mellitus, the Pickwickian syndrome, and metabolic polyarthritis take a milder course. The operation for formation of a small stomach made it possible for the patients to resume their customary occupation, freed them of the threat of invalidation, and reduced the duration of the disability period by 4.3 times. After surgical treatment the nature of the patients' life significantly improved; 95.8% of patients appraised the effect of the treatment as excellent and good.